Michael Wolzt

Vienna, AT 
Vienna, AT 

Overview

Michael Wolzt practices practicing medicine in Vienna, Austria.

His clinical expertise encompasses Gilbert Syndrome, Acute Coronary Syndrome, Chronic Obstructive Pulmonary Disease (COPD), Rotor Syndrome, and Kidney Transplant.

He is actively involved in clinical research, co-authoring 137 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Vienna, 1090, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Placebo-controlled, Double-blind, Cross-over Study to Evaluate the Effect of G-PUR® on Dietary Fumonisin Bioavailability
A Randomized, Placebo-controlled, Double-blind, Cross-over Study to Evaluate the Effect of G-PUR® on Dietary Fumonisin Bioavailability
Enrollment Status: Terminated
Publish Date: November 16, 2020
Intervention Type: Other, Device
Study Phase: Not Applicable
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Effect of Atorvastatin Treatment for 14 Days in Combination With an Acute Dose of Ticagrelor on Ischemia Reperfusion Induced Endothelial Dysfunction of the Forearm Vasculature in Healthy Male Subjects
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Effect of Atorvastatin Treatment for 14 Days in Combination With an Acute Dose of Ticagrelor on Ischemia Reperfusion Induced Endothelial Dysfunction of the Forearm Vasculature in Healthy Male Subjects
Enrollment Status: Completed
Publish Date: March 22, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

137 Total Publications

Donor bone marrow together with recipient regulatory T cells induces chimerism without irradiation in kidney transplantation.
Donor bone marrow together with recipient regulatory T cells induces chimerism without irradiation in kidney transplantation.
Journal: Science translational medicine
Published: June 17, 2026

Frequently Asked Questions about Michael Wolzt

Is Michael Wolzt a top-rated expert for Gilbert Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Michael Wolzt is classified as an Experienced expert for Gilbert Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Michael Wolzt participate in research or clinical trials?

Yes. Michael Wolzt has published 137 articles and abstracts on conditions like Gilbert Syndrome. You can view a list of Michael Wolzt's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wolzt's expertise for a condition
ConditionClose
        View All 16 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile